Jean‐François Héron
- Surgery top 5%
- Reproductive Medicine top 1%
- Oncology top 10%
- Molecular Biology
- Obstetrics and Gynecology top 5%
- Co-authors
- John H. MalfetanoC ScarabelliMartin GoreHenric MalmströmW ten Bokkel HuininkGiorgio BolisJ CarmichaelRobert L. Coleman
- Topics
- Ovarian cancer diagnosis and treatment (10 papers)Intraperitoneal and Appendiceal Malignancies (5 papers)Chemotherapy-induced organ toxicity mitigation (5 papers)
- Partner nations
- FranceLuxembourgUnited Kingdom
In The Last Decade
Jean‐François Héron
28 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Surgery 646
- Reproductive Medicine 577
- Oncology 453
- Molecular Biology 279
- Obstetrics and Gynecology 214
Countries citing papers authored by Jean‐François Héron
This map shows the geographic impact of Jean‐François Héron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Héron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Héron more than expected).
Fields of papers citing papers by Jean‐François Héron
This network shows the impact of papers produced by Jean‐François Héron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Héron. The network helps show where Jean‐François Héron may publish in the future.
Co-authorship network of co-authors of Jean‐François Héron
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐François Héron. A scholar is included among the top collaborators of Jean‐François Héron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐François Héron. Jean‐François Héron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 14 | |
| 3 | 6 | |
| 4 | 47 | |
| 5 | 18 | |
| 6 | 70 | |
| 7 | 79 | |
| 8 | 20 | |
| 9 | Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.breakdown → | 532 |
| 10 | 46 | |
| 11 | Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study. | 8 |
| 12 | Standards, options et recommandations pour une bonne pratique en chimiothérapie | 2 |
| 13 | Methodologie de developpement des standards, options et recommandations diagnostiques et therapeutiques en cancerologie | 15 |
| 14 | 10 | |
| 15 | 56 | |
| 16 | 5 | |
| 17 | [Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)]. | 19 |
| 18 | 12 | |
| 19 | 8 | |
| 20 | 12 |
About Jean‐François Héron
Jean‐François Héron is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Intraperitoneal and Appendiceal Malignancies (5 papers) and Chemotherapy-induced organ toxicity mitigation (5 papers). The work is most often cited by research in Reproductive Medicine (577 citations), Obstetrics and Gynecology (214 citations) and Oncology (453 citations). Jean‐François Héron has collaborated with scholars based in France, Luxembourg and United Kingdom. Frequent co-authors include John H. Malfetano, C Scarabelli, Martin Gore, Henric Malmström, W ten Bokkel Huinink, Giorgio Bolis, J Carmichael, Robert L. Coleman, N. Davidson and Anderley Gordon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.